Evidence map›Paper›PMID 18161883›Full record

ReviewMedicinal research reviews2008

Combination of photodynamic therapy and immunomodulation: current status and future trends.

Yong-Gang Qiang, Christine M N Yow, Zheng Huang

Open access · greenAbstract readReview
In one paragraph

Review in Medicinal research reviews, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. PDT-Induced Activation Enhanced by Hormone Response to Treatment.International journal of molecular sciences · 2023
    Review
  3. Immunomodulators for Non-Melanoma Skin Cancers: Updated Perspectives.Clinical, cosmetic and investigational dermatology · 2023
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Immune stimulating photoactive hybrid nanoparticles for metastatic breast cancer.Integrative biology : quantitative biosciences from nano to macro · 2013
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Yong-Gang QiangDepartment of Experimental Nuclear Medicine, Guangzhou Medical College, Guangzhou, P.R. China.
Christine M N Yow
Zheng Huang
Guangzhou Medical University · CNHong Kong Polytechnic University · HKUniversity of Colorado Health · US

Funding

VERTERINARY PROJECTP01CA043892 · NCI · UNIVERSITY OF COLORADO DENVER · PI HETZEL, FRED W · 1987 to 2008
$9.9M
NCI NIH HHS CA43892NCI NIH HHS P01 CA043892
6 · The paper itself

Abstract

Photodynamic therapy (PDT) has been used for the treatment of nonmalignant and malignant diseases from head to toe. Over the last decade its clinical application has gained increasing acceptance around the world. Pre-clinical studies demonstrate that, in addition to the direct local cytotoxicity and vascular effects, PDT can induce various host immune responses. Recent clinical data also show that improved clinical outcomes are obtained through the combination of PDT and immunomodulation. This review will summarize and discuss recent progress in developing innovative regimen of PDT combined with immunomodulation for the treatment of both nonmalignant and malignant diseases.

Indexed as

Clinical Trials as TopicCombined Modality TherapyHumansImmunologic FactorsPhotochemotherapyImmunologic Factors

Identifiers

PMID18161883
PMCPMC2561284
OpenAlexW2051072398

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.